Tricyclic compounds having antimitotic and/or antitumor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 491/04 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01) C07D 487/04 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2730319

The present invention provides tricyclic compounds, pharmaceutically acceptable salts, prodrugs, solvates, or hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, for example P-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxal sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds for treating tumor cells and inhibiting mitosis of cancerous cells.

La présente invention porte sur des composés tricycliques, sur des sels, promédicaments, solvates ou hydrates pharmaceutiquement acceptables de ceux-ci, ayant une activité antimitotique, une activité de résistance contre plusieurs médicaments, par exemple une inhibition de la glycoprotéine P, et une activité antitumorale, et qui inhibent des cellules tumorales sensibles et résistantes au paclitaxel. L'invention porte également sur des procédés d'utilisation de ces composés pour le traitement des cellules tumorales et l'inhibition de la mitose de cellules cancéreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic compounds having antimitotic and/or antitumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic compounds having antimitotic and/or antitumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds having antimitotic and/or antitumor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1868171

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.